Experts Say Truvada Should Remain First Choice in Pre-exposure Prophylaxis for Most Patients with HIV
Robust data show the efficacy of tenofovir disoproxil fumarate with emtricitabine for pre-exposure prophylaxis.
FDA Approval, Regulation Process Accepts Less Data, Shortens Review Times
Report demonstrates an increase in generic and new drug approvals, Orphan Drug designations.
Judge denies motion to dismiss lawsuit after examining federal and state statutes.
The easiest way to avoid misdiagnosis, inappropriate treatment, and potential loss of reimbursement is to prevent unsuitable testing.
Almost one-third of those who suffer are treatment resistant, which can pose challenges.
Various practice settings can provide these services, and independent pharmacies may be the perfect fit.
Now in 4 states, the program allows providers to admit errors without worry about legal ramifications in the courtroom.
Learn about OTC preventions for influenza, handling flu and diabetes, and more.
Chronic obstructive pulmonary disease (COPD) leads in hospital costs, physician services, and prescription drugs.
Advances in research and immunotherapy have led to breakthroughs regarding biologics targeting melanoma.
Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, discusses best uses for opioids, and when to use other pain medications. This video was filmed at the 54th ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.
A blood-based screening test using cell-free DNA may be able to identify cancer at earlier stages than what was previously possible, according to research to be presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, held January 23 to 25 in San Francisco.
The CDC is making strides toward better understanding the pneumonia-like coronavirus (2019-nCoV) that originated in Wuhan, China.
Top news of the day from across the health care landscape.